Web Stats Provided By Google Analytics

Wednesday, January 29, 2014

AHF to Ask States to Block Gilead's $1,000 per Pill Hepatitis Drug From Medicaid Formularies

... Foundation. "At that time, Stribild's price was 35% more than Atripla, the company's best selling combination HIV/AIDS treatment, and made Stribild the highest priced first-line combination AIDS therapy. Now, Gilead has set a new benchmark for ...

http://ift.tt/1fy2LPn

No comments:

Post a Comment